Seha Care Basic Quarterly (THB) at Dr. Essa Lab

Seha Care Basic Quarterly (THB) at Dr. Essa Lab

The Seha Care Basic Quarterly (THB) at Dr. Essa Lab is a comprehensive, preventive health screening panel designed to monitor vital physiological markers and metabolic functions. In modern preventive medicine, routine diagnostic evaluation is the cornerstone of early disease detection and long-term wellness management. This specialized quarterly panel is meticulously curated to evaluate key organ systems, including the hematopoietic system, renal filtration pathways, hepatic metabolic functions, and cardiovascular risk profiles. By analyzing blood and urine specimens, this diagnostic panel provides clinicians and patients with a highly accurate, objective assessment of baseline health, allowing for early intervention before clinical symptoms manifest.

Dr. Essa Laboratory & Diagnostic Centre, established in 1987 in Karachi, Pakistan, utilizes advanced automated analyzers and strict quality control protocols to perform the Seha Care Basic Quarterly (THB). This panel serves as an essential health surveillance tool for individuals seeking to maintain optimal wellness, manage chronic metabolic conditions, or proactively screen for silent pathological shifts. The diagnostic value of this panel lies in its multi-system approach, integrating hematology, biochemistry, and urinalysis into a single, cohesive clinical profile. Through regular quarterly monitoring, patients can track physiological trends, assess the efficacy of dietary or therapeutic interventions, and collaborate with their healthcare providers to make informed decisions regarding their long-term health strategy.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost diagnostic accuracy and prevent pre-analytical errors, patients must adhere to specific preparation guidelines prior to undergoing the Seha Care Basic Quarterly (THB) at Dr. Essa Lab. Because this panel includes metabolic markers such as fasting blood glucose and a comprehensive lipid profile, a strict fasting period of 10 to 12 hours is mandatory. During this fasting window, patients must abstain from all food, caloric beverages, juices, tea, and coffee. Adequate hydration with plain, non-carbonated water is highly encouraged, as it maintains intravascular volume and facilitates easier venipuncture.

Patients should avoid strenuous physical exercise and alcohol consumption for at least 24 hours before the test, as these activities can transiently alter liver enzymes, lipid levels, and renal markers. It is crucial to consult with the prescribing physician regarding the administration of daily medications. Most routine prescription drugs, such as antihypertensives, can be taken with water, but certain medications or dietary supplements (such as biotin or high-dose vitamins) may interfere with specific assays and should be disclosed to the phlebotomist prior to sample collection.

During the Procedure

Upon arriving at Dr. Essa Lab, the patient is received by a trained phlebotomist who verifies the patient's identity, fasting status, and clinical indications. The procedure is conducted in a highly sterile, comfortable environment. The patient is seated comfortably, and the phlebotomist identifies a suitable vein, typically the median cubital vein in the antecubital fossa of the arm. The area is thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) and allowed to air dry to prevent hemolysis of the specimen.

A sterile, single-use needle is inserted into the vein, and blood is drawn into specific vacuum-sealed tubes. These typically include an EDTA tube for hematological analysis, a sodium fluoride tube for precise glucose preservation, and a serum separator tube for biochemical assays. The process is rapid, generally taking less than five minutes, and causes minimal discomfort, often described as a mild pinch. After the needle is withdrawn, gentle pressure is applied to the puncture site with a sterile cotton ball, followed by the application of an adhesive bandage to prevent hematoma formation. A midstream urine sample is also collected in a sterile container provided by the laboratory to complete the urinalysis portion of the panel.

When is a Seha Care Basic Quarterly (THB) Performed?

Routine Wellness and Preventive Health Monitoring

Physicians frequently recommend the Seha Care Basic Quarterly (THB) at Dr. Essa Lab as a routine wellness check for asymptomatic individuals. Many chronic diseases, including early-stage chronic kidney disease, hepatic steatosis, and prediabetes, progress silently without presenting overt physical symptoms. By performing this panel on a quarterly basis, healthcare providers can establish a personalized physiological baseline for the patient, enabling the detection of subtle deviations that may indicate early organ dysfunction or metabolic imbalance.

Monitoring Chronic Metabolic Conditions

For patients diagnosed with metabolic syndrome, prediabetes, or stable type 2 diabetes, this quarterly panel is an invaluable tool for tracking glycemic control and systemic health. Regular monitoring of fasting blood glucose, alongside lipid parameters, allows clinicians to evaluate the clinical efficacy of lifestyle modifications, dietary changes, and pharmacological therapies. It provides the objective data necessary to titrate medication dosages and prevent long-term microvascular and macrovascular complications associated with poorly managed metabolic disorders.

Evaluating Unexplained Fatigue and Lethargy

Chronic fatigue, weakness, and decreased exercise tolerance are common clinical complaints that warrant systemic investigation. The hematological and biochemical components of the Seha Care Basic Quarterly (THB) help clinicians rule out common physiological causes of fatigue, such as iron-deficiency anemia, vitamin deficiencies, systemic infections, or subclinical organ dysfunction. By evaluating red blood cell indices and metabolic markers, the test assists in identifying the underlying etiology of systemic lethargy.

Assessment of Cardiovascular Risk Factors

Cardiovascular diseases remain a leading cause of morbidity and mortality globally. The lipid profile included in this quarterly panel measures total cholesterol, triglycerides, high-density lipoprotein (HDL), and low-density lipoprotein (LDL). Physicians request this test to assess an individual's cardiovascular risk profile, monitor the progress of lipid-lowering therapies (such as statins), and implement preventive strategies to mitigate the risk of atherosclerosis, myocardial infarction, and cerebrovascular accidents.

Screening for Hepatic and Renal Dysfunction

The liver and kidneys are the primary organs responsible for metabolism, detoxification, and waste excretion. Exposure to environmental toxins, polypharmacy, chronic alcohol consumption, or underlying viral infections can compromise these organs silently. The Seha Care Basic Quarterly (THB) evaluates key hepatic enzymes and renal waste products, allowing physicians to screen for early signs of hepatotoxicity, fatty liver disease, or declining glomerular filtration rate, ensuring timely clinical intervention.

What Does a Seha Care Basic Quarterly (THB) Detect?

The Seha Care Basic Quarterly (THB) at Dr. Essa Lab is designed to detect a wide array of physiological abnormalities, pathological conditions, and metabolic imbalances. Through its comprehensive multi-parameter analysis, this panel can identify:

• Microcytic Hypochromic Anemia: Indicated by reduced hemoglobin, hematocrit, and mean corpuscular volume (MCV), commonly associated with iron deficiency.
• Macrocytic Anemia: Characterized by elevated MCV, often pointing to Vitamin B12 or folate deficiencies.
• Infectious Processes: Detected via elevated white blood cell (WBC) counts (leukocytosis) or abnormal differential counts.
• Bone Marrow Suppression: Suggested by abnormally low WBC, red blood cell (RBC), or platelet counts (pancytopenia).
• Thrombocytopenia: Low platelet counts, which increase the risk of spontaneous bleeding or bruising.
• Thrombocytosis: Elevated platelet counts, which may indicate chronic inflammation or bone marrow disorders.
• Impaired Fasting Glucose (Prediabetes): Fasting blood sugar levels that are higher than normal but not yet in the diabetic range.
• Diabetes Mellitus: Markedly elevated fasting blood glucose levels indicating insulin resistance or insufficient insulin production.
• Hypercholesterolemia: Elevated total cholesterol levels, a major risk factor for coronary artery disease.
• Hypertriglyceridemia: High triglyceride levels, which can contribute to arterial hardening or acute pancreatitis.
• Atherogenic Dyslipidemia: Elevated low-density lipoprotein (LDL) and decreased high-density lipoprotein (HDL) levels.
• Hepatocellular Injury: Elevated levels of Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST), indicating liver cell damage.
• Cholestasis: Elevated Alkaline Phosphatase (ALP) and bilirubin levels, suggesting biliary obstruction or gallbladder disease.
• Impaired Renal Clearance: Elevated blood urea nitrogen (BUN) and serum creatinine levels, indicating reduced kidney filtration capacity.
• Hyperuricemia: Elevated uric acid levels, which can lead to gouty arthritis or renal calculi (kidney stones).
• Urinary Tract Infection (UTI): Detected via the presence of leukocyte esterase, nitrites, bacteria, and pus cells in the urine.
• Renal Glomerular Damage: Indicated by the presence of protein (proteinuria) or microalbumin in the urine.
• Renal Hematuria: The presence of red blood cells in the urine, suggesting stones, infection, or glomerular disease.
• Glucosuria: Glucose in the urine, typically occurring when blood glucose levels exceed the renal threshold.
• Ketonuria: The presence of ketones in the urine, indicating altered fat metabolism, starvation, or diabetic ketoacidosis.
• Systemic Dehydration: Indicated by elevated urine specific gravity and concentrated biochemical markers.
• Acid-Base Imbalances: Detected through abnormal urine pH levels, reflecting systemic metabolic or respiratory alterations.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Laboratory & Diagnostic Centre is committed to providing rapid, accurate, and reliable diagnostic reports. For the Seha Care Basic Quarterly (THB), the standard turnaround time is typically within 12 to 24 hours from the time of sample collection. Because the panel utilizes automated, high-throughput analyzers, the processing time is minimized while maintaining stringent quality control standards.

Patients can access their diagnostic reports through multiple convenient channels. Once the results are verified by a consultant pathologist, an automated SMS notification containing a secure download link is sent to the patient's registered mobile number. Reports can also be accessed and downloaded directly from the official Dr. Essa Lab website using the unique patient ID and password provided on the receipt. For patients who prefer physical copies, printed reports can be collected from any official Dr. Essa Lab collection center or main branch.

Seha Care Basic Quarterly (THB) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hemoglobin (Hb)	Male: 13.5–17.5 g/dL Female: 12.0–15.5 g/dL	Decreased: Anemia (iron deficiency, chronic disease) Increased: Polycythemia, chronic hypoxia
White Blood Cells (WBC)	4,500–11,000 cells/mcL	Increased: Infection, inflammation, leukemia Decreased: Viral infections, autoimmune conditions, bone marrow failure
Fasting Blood Glucose	70–99 mg/dL	Increased: Prediabetes, Diabetes Mellitus, endocrine disorders Decreased: Hypoglycemia, insulinoma
Serum Creatinine	Male: 0.6–1.2 mg/dL Female: 0.5–1.1 mg/dL	Increased: Acute kidney injury, chronic kidney disease, dehydration Decreased: Muscle wasting, severe malnutrition
Alanine Aminotransferase (ALT)	7–56 U/L	Increased: Hepatitis, fatty liver, liver cirrhosis, drug-induced liver injury
Total Cholesterol	Less than 200 mg/dL	Increased: Hypercholesterolemia, cardiovascular disease risk, hypothyroidism
Uric Acid	Male: 3.4–7.0 mg/dL Female: 2.4–6.0 mg/dL	Increased: Gout, renal insufficiency, tumor lysis syndrome Decreased: Low purine diet, Wilson's disease
Urine Protein	Negative / Trace	Positive: Nephrotic syndrome, diabetic nephropathy, glomerulonephritis, hypertension

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Seha Care Basic Quarterly (THB)?

• Experienced Healthcare Professionals: Dr. Essa Lab is guided by highly qualified consultant pathologists, microbiologists, and biochemists who ensure clinical excellence.
• Patient-Focused Care: Every patient receives personalized attention, ensuring a comfortable, stress-free diagnostic experience from registration to reporting.
• Quality Diagnostic Services: Operating with ISO 9001:2015 certification, the laboratory adheres to international diagnostic standards and external quality assurance programs.
• Professional Reporting: Reports are verified by specialized pathologists, ensuring clinical accuracy and clear, actionable diagnostic data.
• Modern Diagnostic Approach: The laboratory utilizes state-of-the-art, fully automated analyzers that minimize human error and enhance analytical precision.
• Comfortable Environment: All collection centers are designed to maintain the highest standards of hygiene, patient comfort, and safety.
• Convenient Location: With an extensive network of branches across Karachi and other major cities, accessing diagnostic services is highly convenient.
• Commitment to Accurate Diagnosis: Dr. Essa Lab has maintained a legacy of trust and diagnostic integrity in Pakistan since its inception in 1987.